Your browser doesn't support javascript.
loading
Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer.
Narita, Shintaro; Nomura, Kyoko; Hatakeyama, Shingo; Takahashi, Masahiro; Sakurai, Toshihiko; Kawamura, Sadafumi; Hoshi, Senji; Ishida, Masanori; Kawaguchi, Toshiaki; Ishidoya, Shigeto; Shimoda, Jiro; Sato, Hiromi; Mitsuzuka, Koji; Tochigi, Tatsuo; Tsuchiya, Norihiko; Ohyama, Chikara; Arai, Yoichi; Nagashima, Kengo; Habuchi, Tomonori.
Afiliação
  • Narita S; Department of Urology, Akita University School of Medicine, Akita, Japan. nari6202@gipc.akita-u.ac.jp.
  • Nomura K; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan. nari6202@gipc.akita-u.ac.jp.
  • Hatakeyama S; Department of Environmental Health Science and Public Health, Akita University School of Medicine, Akita, Japan.
  • Takahashi M; Department of Urology, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Sakurai T; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Kawamura S; Department of Urology, Tohoku University School of Medicine, Sendai, Japan.
  • Hoshi S; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Ishida M; Department of Urology, Yamagata University School of Medicine, Yamagata, Japan.
  • Kawaguchi T; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Ishidoya S; Department of Urology, Miyagi Cancer Center, Miyagi, Japan.
  • Shimoda J; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Sato H; Department of Urology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Mitsuzuka K; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Tochigi T; Department of Urology, Iwate Prefectural Isawa Hospital, Isawa, Japan.
  • Tsuchiya N; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Ohyama C; Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Arai Y; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Nagashima K; Department of Urology, Sendai City Hospital, Sendai, Japan.
  • Habuchi T; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
Sci Rep ; 9(1): 12071, 2019 08 19.
Article em En | MEDLINE | ID: mdl-31427687
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno Prostático Específico / Fosfatase Alcalina / Antagonistas de Androgênios Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno Prostático Específico / Fosfatase Alcalina / Antagonistas de Androgênios Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido